Alnylam Pharmaceuticals
ALNY
ALNY
401 hedge funds and large institutions have $21B invested in Alnylam Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 154 increasing their positions, 120 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 398 → 401 (+3)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
1.59% less ownership
Funds ownership: 95.49% → 93.9% (-1.6%)
Holders
401
Holding in Top 10
9
Calls
$275M
Puts
$138M
Top Buyers
| 1 | +$66M | |
| 2 | +$52.9M | |
| 3 | +$43.8M | |
| 4 |
BlackRock
New York
|
+$42.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.9M |
Top Sellers
| 1 | -$341M | |
| 2 | -$54.5M | |
| 3 | -$50.6M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$28.3M |
| 5 |
JPMorgan Chase & Co
New York
|
-$27M |